European Archives - Page 345 of 1262 - European Medical Journal

Interview: Samuel Seidu

The main findings of the paper revealed that Black patients were underrepresented in clinical trials, particularly with respect to the newer diabetes therapies, sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists.

Redefining Eosinophilic Oesophagitis (EoE) Control: Elevating Patient Lives Beyond Symptom Suppression

The dynamic treatment landscape for eosinophilic oesophagitis (EoE) continues to emphasise symptom relief, often neglecting the underlying…

EMJ Diabetes 12.1 2024

We are delighted to announce the release of the latest EMJ Diabetes journal! Inside you will discover a wide range of content, including…

Review of the European Association for the Study of Diabetes (EASD) Annual Meeting 2024

ATTENDEES were warmly welcomed to a “feast of science” at the 60th European Association for the Study of Diabetes (EASD) Annual Meeting…

Managing Respiratory Diseases

Meal Timing: Its Relation to Metabolism and Heritability

Meal timing is a crucial factor influencing metabolic health, which can be explained by the tight interaction between circadian clocks and…

The Impact of Gestational Diabetes on Long-Term Kidney Disease

Gestational diabetes mellitus (GDM) is a pervasive metabolic disorder associated with a spectrum of long-term adverse outcomes. Recent…

The latest issue of EMJ Diabetes

The latest edition of EMJ Diabetes is out now, featuring key insights from EASD 2024. Discover the impact of circadian meal timing on…

Screening and Monitoring for Presymptomatic Type 1 Diabetes

Type 1 diabetes (T1D), coeliac disease (CD), and autoimmune thyroid disease (AITD), abbreviated as TRIAD diseases, are three common…

Consequences of Disintegrated Care for Dual Tuberculosis and Diabetes

Diabetes is known to be a risk factor for active pulmonary tuberculosis (TB) and the reactivation of latent or previous TB. It is also…